In silico assessment of class I antiarrhythmic drug effects on pitx2‐induced atrial fibrillation: Insights from populations of electrophysiological models of human atrial cells and tissues

Abstract

Electrical remodelling as a result of homeodomain transcription factor 2 (Pitx2)‐dependent gene regulation was linked to atrial fibrillation (AF) and AF patients with single nucleotide poly-morphisms at chromosome 4q25 responded favorably to class I antiarrhythmic drugs (AADs). The possible reasons behind this remain elusive. The purpose of this study was to assess the efficacy of the AADs disopyramide, quinidine, and propafenone on human atrial arrhythmias mediated by Pitx2‐induced remodelling, from a single cell to the tissue level, using drug binding models with multi‐channel pharmacology. Experimentally calibrated populations of human atrial action po‐ten-tial (AP) models in both sinus rhythm (SR) and Pitx2‐induced AF conditions were constructed by using two distinct models to represent morphological subtypes of AP. Multi‐channel pharmacological effects of disopyramide, quinidine, and propafenone on ionic currents were considered. Sim-ulated results showed that Pitx2‐induced remodelling increased maximum upstroke velocity (dVdtmax), and decreased AP duration (APD), conduction velocity (CV), and wavelength (WL). At the concentrations tested in this study, these AADs decreased dVdtmax and CV and prolonged APD in the setting of Pitx2‐induced AF. Our findings of alterations in WL indicated that disopyra-mide may be more effective against Pitx2‐induced AF than propafenone and quinidine by prolonging WL.